Additionally, overexpression of TMEM213 in breast tumors was found to be associated with better survival (Supplementary Figure S4b); we suggest that the generally observed increased expression and/or hyperactivation of PI-3 kinase/AKT signaling might impair the expression of TMEM213 and the resulting role in cancer progression. The gene discussed is AKT1; the disease is cancer.